- Home
- ATHE vs BNGO Comparison
ATHE vs BNGO Comparison
Compare ATHE & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHE
- BNGO
- Stock Information
- Founded
- ATHE 1997
- BNGO 2003
- Country
- ATHE Australia
- BNGO United States
- Employees
- ATHE N/A
- BNGO N/A
- Industry
- ATHE Biotechnology: Pharmaceutical Preparations
- BNGO Biotechnology: Laboratory Analytical Instruments
- Sector
- ATHE Health Care
- BNGO Industrials
- Exchange
- ATHE Nasdaq
- BNGO Nasdaq
- Market Cap
- ATHE 21.4M
- BNGO 24.3M
- IPO Year
- ATHE N/A
- BNGO 2018
- Fundamental
- Price
- ATHE $4.75
- BNGO $4.84
- Analyst Decision
- ATHE Strong Buy
- BNGO Hold
- Analyst Count
- ATHE 2
- BNGO 3
- Target Price
- ATHE $8.00
- BNGO $1.00
- AVG Volume (30 Days)
- ATHE 1.3M
- BNGO 289.4K
- Earning Date
- ATHE 02-15-2025
- BNGO 03-04-2025
- Dividend Yield
- ATHE N/A
- BNGO N/A
- EPS Growth
- ATHE N/A
- BNGO N/A
- EPS
- ATHE N/A
- BNGO N/A
- Revenue
- ATHE $2,681,669.00
- BNGO $33,334,000.00
- Revenue This Year
- ATHE N/A
- BNGO N/A
- Revenue Next Year
- ATHE N/A
- BNGO $6.18
- P/E Ratio
- ATHE N/A
- BNGO N/A
- Revenue Growth
- ATHE 2.63
- BNGO N/A
- 52 Week Low
- ATHE $1.00
- BNGO $4.75
- 52 Week High
- ATHE $5.87
- BNGO $81.00
- Technical
- Relative Strength Index (RSI)
- ATHE 75.45
- BNGO 29.16
- Support Level
- ATHE $2.76
- BNGO $4.95
- Resistance Level
- ATHE $5.14
- BNGO $5.89
- Average True Range (ATR)
- ATHE 0.42
- BNGO 1.28
- MACD
- ATHE 0.15
- BNGO -0.56
- Stochastic Oscillator
- ATHE 71.14
- BNGO 5.07
About ATHE Alterity Therapeutics Limited
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.